Table 1.
Roles of stress-related pathways including the cGAS-STING pathway in regulating HSPC maintenance.
Species | Context | Target | Target cells | Outcome | Mechanism | Reference |
---|---|---|---|---|---|---|
Mouse | Homeostasis | cGAS-STING pathway | HSCs | Proliferation; Reduced self-renewal |
Cia-cGAS is a suppressor of cGAS. Cia-cGAS deficiency results in the hyperactivation of cGAS-STING pathway and increased production of IFN-I. | (15) |
Mouse | Homeostasis | cGAS-STING pathway | HSPCs | Proliferation | DDX41 insufficiency results in excessive R-loop accumulation, which subsequently activate cGAS-STING-NF-κB pathway to promote HSPC expansion. | (53) |
Mouse | Homeostasis | cGAS-STING pathway | HSCs | Proliferation; Reduced self-renewal |
Apoptotic caspases deficiency triggers the release of mtDNA, which induces the constitutive activation of cGAS-STING pathway and increased IFN-I production. | (54) |
Mouse | c-di-GMP administration | cGAS-STING pathway | HSPCs | Proliferation; Myeloid-biased differentiation; Mobilization; Reduced self-renewal |
Bacterial c-di-GMP activates STING pathway in a cGAS-independent manner, the downstream IRF3/IFN-I signaling induces HSPC proliferation and myeloid-biased differentiation but reduces HSC self-renewal and mobilization; the downstream NF-κB/G-CSF and JNK/TGF-β promotes HSC mobilization. | (55) |
Mouse | Homeostasis | IRF1/IRF2 | HSCs | Proliferation; Reduced self-renewal |
IRF1 is a downstream effector of both cGAS-STING pathway and IFN-I signaling. IRF2 can repress IRF1 through competitively binding to the promoter of target genes. IRF1 activation or IRF2 deficiency will promote proliferation but reduce self-renewal of HSCs. | (56) |
Mouse | Genotoxic stress (IR) | IRF5 | HSPCs | Proliferation; Apoptosis |
IRF5 is a downstream effector of both cGAS-STING pathway and IFN-I signaling. IRF5 is upregulated and may contribute to increased proliferation, replication stress, and apoptosis of HSPC after IR. | (57) |
Mouse; Zebrafish |
Homeostasis | IRF7 | HSCs | Myeloid-biased differentiation; Reduced HSC development |
IRF7 is a downstream effector of both cGAS-STING pathway and IFN-I signaling. IRF7 activation will reduce HSC formation in the AGM region and T cell differentiation of HSCs. | (58) |
Human; Mouse |
Infection; Inflammation |
NF-κB | HSCs | Proliferation; Myeloid-biased differentiation; Reduced self-renewal |
NF-κB is a main downstream effector of both cGAS-STING pathway and cytokine signaling such as IL1 and TNF. NF-κB can induce the transcriptional activation of myeloid transcription factor PU.1. | (59–62) |
Mouse | Homeostasis | TRAF6/IKK/NF-κB | HSCs | Proliferation; Myeloid-biased differentiation; Reduced self-renewal |
TRAF6 or IKK deficiency-induced reduction of basal NF-κB signaling can promote proliferation and myeloid-biased differentiation but reduce self-renewal of HSCs. | (63) |
Human; Mouse |
Homeostasis; Stress |
mTOR or MAPKs | HSCs | Proliferation; Myeloid-biased differentiation; Reduced self-renewal |
mTOR or MAPKs signaling activation is associated with increased proliferation and myeloid-biased differentiation, but reduced self-renewal of HSCs. | (29, 64–66) |
Mouse | pI:C administration | IFN-I signaling | HSPCs | Proliferation; Myeloid-biased differentiation |
Acute IFN-I signaling activates STAT1 and Akt/mTOR to upregulate the expression of Sca-1 and myeloid markers in HSPCs. Besides, IFN-I can also upregulate IRFs in a positive feedback manner. | (55, 56, 67–69) |
Mouse; Zebrafish |
Homeostasis; LPS and Pam3CSK4 administration Genotoxic stress (Chemotherapeutic agent [5-FU]); Aging |
IL-6 signaling | HSPCs | Proliferation; Myeloid-biased differentiation; Reduced self-renewal |
IL-6 signaling may engage the Akt/mTOR and SHP2/STAT3 pathway to modulate HSPC maintenance. Besides, it is a particularly important modulator in mediating rapid myeloid cell recovery during chemotherapy-induced neutropenia. | (48, 70, 71), |
Mouse | Transplantation; Inflammation |
TNF signaling | HSCs | Reduced clonal growth and self-renewal | TNF can strongly inhibit the clonal growth and compromise the repopulation capacity of HSPCs that engages its two distinct receptors. | (72) |
Human; Mouse |
Infection; Inflammation |
NF-κB | HSPCs | Reduced necroptosis | NF-κB can induce the transcriptional activation of cIAP2, which can inhibit RIPK3/MLKL-mediated necroptosis. | (62) |
Human; Mouse | Infection; DNA introduction; pI:C administration |
IFN-I signaling | HSCs | Inhibited proliferation; Apoptosis; Necroptosis |
Chronic IFN-I signaling may inhibit HSC proliferation and trigger p53 and RIPK1-CASP8 pathway-mediated apoptosis, or RIPK3- and MLKL-mediated necroptosis of HSCs. | (36, 73, 74), |
Mouse | pI:C administration | IFN-I signaling | HSCs | DNA damage | IFN-I signaling induces mitochondrial ROS overproduction and causes DNA damage in HSCs. | (46) |